UK drug agency announces review of use of alteplase after stroke

BMJ. 2014 Sep 1:349:g5355. doi: 10.1136/bmj.g5355.
No abstract available

Publication types

  • News

MeSH terms

  • Brain Ischemia / drug therapy*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Product Surveillance, Postmarketing
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / therapeutic use*
  • United Kingdom

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator